Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25680731 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL25680746 | 0.99 | CA12 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL26304183 | 0.98 | CA12 (0.50) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL24770324 | 0.98 | CA12 (0.50) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL26291006 | 0.98 | CA12 (0.50) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL25471687 | 0.98 | ALDH1A1 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL24770267 | 0.98 | ALDH1A1 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL27257038 | 0.98 | ALDH1A1 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL26291003 | 0.98 | CA12 (0.50) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL26605969 | 0.98 | CA12 (0.50) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | ESR1, EML4, ORAI2 | CA12 765/4885CA1 982/4885CA2 826/4885 |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | ESR1, EML4, ORAI2 | CA12 765/4885CA1 982/4885CA2 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.